According to previous findings, the m6A writer, METTL14, acts as a tumor-suppressing factor in ccRCC, characterized by inhibiting metastasis of cancer cells by repressing expression of BPTF and P2RX6 [28, 29]. Here, METTL14 is linked to nonpapillary renal cell carcinoma.